HGH SINGLE VIALS
View available single-vial options.
THE RESEARCH IN 60 SECONDS
Three distinctions worth knowing
Lean mass is not strength
Measured lean mass can change with extracellular water. Trials must report strength separately. [1]
Study populations matter
Evidence in diagnosed GH deficiency cannot automatically be applied to healthy adults. [2]
Sleep research has limits
Observing a natural GH pulse during deep sleep does not establish HGH as a sleep treatment. [3]
WATCH THE RESEARCH
HGH — educational video
Jump to a moment
Read the full video transcript
What if one hormone played a role in muscle development, skin health, and even what happens while you sleep? For decades, this hormone has been used in bodybuilding because of its effects on lean body mass, but increased muscle size doesn't always mean increased strength. It also influences collagen production and tissue maintenance, and here's something fascinating. Your body releases a major pulse of it during deep sleep. Manufactured versions have been approved for decades to treat specific medical conditions, including growth hormone deficiency in children and adults. From muscle and skin biology to metabolism, this is much more than just a growth signal.
Video captions are also available using the player controls.
Human growth hormone (GH, often called HGH) influences growth and metabolism. Somatropin is manufactured human GH used in prescription medicine. But evidence from healthy athletes, people with diagnosed GH deficiency, and natural-sleep studies cannot be interpreted as one interchangeable result. This research guide explains what the studies measured, what they found, and their limits. It does not evaluate any retail product or offer treatment instructions.
A CLEAR FOUNDATION
The basics
What is HGH?
HGH is shorthand for human growth hormone, also called GH or somatotropin. Somatropin is the recombinant form used in named prescription medicines. The body naturally secretes GH in pulses. [4][3]
What happens after growth hormone is released?
GH binds to receptors in multiple tissues. Some biological effects occur directly, while others involve insulin-like growth factor 1 (IGF-1), including IGF-1 produced in response to GH signaling. Biological pathways do not by themselves establish a clinical benefit. [5]
Is lean body mass the same as muscle growth?
No. Lean body mass includes water, organs, bone and other non-fat tissues in addition to muscle. The recreational-athlete trial measured extracellular water and strength separately, which is why those outcomes should not be equated. [1]
Why diagnosis and study population matter
A study of replacement treatment in patients with diagnosed growth hormone deficiency answers a different question than a study in healthy athletes or adults without a diagnosed deficiency. The Endocrine Society guideline addresses clinically confirmed deficiency, not routine use in healthy people. [6][1]
VISUAL EXPLAINER
How GH and IGF-1 signaling connect
An overview of biological signaling, not a claim of a particular treatment outcome.
READ THE MEASUREMENT
Why “lean body mass” does not equal new muscle
Lean mass groups several different kinds of non-fat tissue together. The illustration shows categories, not their percentages or a study-specific body composition.
HGH SINGLE VIALS
View available single-vial options.
At a glance
- In a trial of 96 recreational athletes, growth hormone changed body composition, but most measured physical-performance outcomes, including strength, did not significantly improve.
- An increase in lean body mass is not a direct measure of muscle-fiber growth or strength; extracellular water can contribute to the measured change.
- A small study in diagnosed GH deficiency reported changes in collagen synthesis and skin thickness; it did not demonstrate cosmetic benefits for healthy adults.
- Natural GH pulses during deep sleep do not mean taking somatropin improves sleep.
- Prescription GH has clinical indications and documented risks. Research findings do not verify a retail product.
Evidence in this guide: Randomized trials in recreational athletes and GH-deficient adults, a small sleep physiology study, a systematic review in healthy older adults, a specialist guideline and current prescription-label safety information. They answer different questions.
ORIGINAL EVIDENCE
Human studies at a glance
The numbers describe study samples or study populations, not proof of benefit or safety. Open each section for its measured outcomes and limitations.
Recreational athletes
Eight-week randomized trial with six-week follow-up [1]
Explore this studyGH-deficient adults
18 assessable at study completion; collagen and skin thickness measured [2]
Explore this studyYoung adults
Seven showed a major GH peak associated with deep sleep [3]
Explore this studyStudy populations
Systematic review of trials in healthy older adults [7]
Explore this studySelected sources at a glance
Compare the research context, reported findings and limitations already explained in this guide. These notes are a selected-source summary, not a systematic review.
| Evidence and sources | Who or what was studied? | What was reported? | Interpretation limit |
|---|---|---|---|
| Randomized, blinded human trial[1] | 96 recreationally trained athletes (63 men, 33 women), with eight weeks of treatment and a six-week observation period after stopping. Men had additional testosterone and combination-treatment groups. | GH reduced fat mass and increased measured lean body mass, partly through extracellular water. Sprint capacity increased by 3.9% across men and women combined in the GH comparison; the combined GH-and-testosterone group in men showed a larger observed sprint change. Strength, jump power and endurance measures did not significantly change. | The trial was not large enough to establish safety. The sprint effect was not maintained six weeks after treatment stopped. A change in lean body mass must not be interpreted automatically as increased functional muscle or strength. |
| Double-blind controlled trial in diagnosed deficiency[2] | 20 adults with growth hormone deficiency and hypopituitarism enrolled in a 12-month randomized study; 18 were assessable at the end. The first six months included a placebo comparison. | After six months, a blood marker of type I collagen synthesis was higher with GH replacement than with placebo. Researchers also reported significant increases in measured skin thickness at their studied sites during GH substitution. | This was replacement treatment for diagnosed hormone deficiency. It does not demonstrate wrinkle reduction, anti-aging benefit or equivalent effects in healthy people. |
| Small human physiology study[3] | Eight young adults were observed over 38 study nights using overnight blood sampling and sleep-stage measurements. | Seven of eight participants had a major GH secretion peak associated with the onset of deep sleep. Delaying the onset of sleep delayed that peak. | This observed endogenous hormone secretion. It did not administer HGH or test whether taking GH improves sleep quality, duration or recovery. |
| Specialist clinical practice guideline[6][4] | Adults evaluated for clinically confirmed growth hormone deficiency, often related to pituitary disease or childhood-onset deficiency. | The Endocrine Society describes benefits of appropriately selected GH replacement in body composition, exercise capacity and some other measures in adults with diagnosed deficiency. The guideline usually calls for confirmation using appropriate testing. | Clinical treatment in confirmed deficiency is not evidence that GH is indicated or suitable for otherwise healthy adults, bodybuilding or cosmetic use. Decisions about prescription treatment require individual medical evaluation. |
| Systematic review of controlled trials[7] | A review of 18 unique study populations in community-dwelling older adults without a specific illness being treated; 220 GH recipients completed the included studies. | Across included trials, GH produced relatively small average changes in measured fat and lean mass, while adverse events including edema, joint symptoms and carpal tunnel syndrome were more frequent. | The review found insufficient justification for GH as an anti-aging therapy. Its participants, study designs and treatment durations differ from those in the athlete and deficiency studies. |
| Official U.S. prescription label and systematic review[4][7] | Patients receiving approved somatropin products in clinical care, and older adults included in GH trials. | The GENOTROPIN label documents fluid retention, joint and nerve-compression symptoms, changes in glucose regulation, intracranial hypertension and other serious warnings or contraindications. Clinicians monitor relevant risks during prescribed treatment. | Not everyone experiences these events, and risks depend on the individual and clinical context. This is a selected summary, not the full label, and it does not establish safety or quality for any retail product. |
| Official prescription label[4] | Patients meeting the named prescription medicine’s indications and diagnostic criteria. | GENOTROPIN labeling includes defined pediatric indications and adult growth hormone deficiency. It also identifies contraindications, warnings and precautions for clinical prescribing. | Approval and prescribing standards apply to the specific medicine and indicated circumstances. They do not confer approval, equivalence or clinical suitability on a research-product listing. |
Did HGH increase muscle mass or strength in athletes?
- Who or what was studied?
- 96 recreationally trained athletes (63 men, 33 women), with eight weeks of treatment and a six-week observation period after stopping. Men had additional testosterone and combination-treatment groups.
- What did the source report?
- GH reduced fat mass and increased measured lean body mass, partly through extracellular water. Sprint capacity increased by 3.9% across men and women combined in the GH comparison; the combined GH-and-testosterone group in men showed a larger observed sprint change. Strength, jump power and endurance measures did not significantly change. [1]
Keep in context
The trial was not large enough to establish safety. The sprint effect was not maintained six weeks after treatment stopped. A change in lean body mass must not be interpreted automatically as increased functional muscle or strength.
What did researchers observe about collagen and skin thickness?
- Who or what was studied?
- 20 adults with growth hormone deficiency and hypopituitarism enrolled in a 12-month randomized study; 18 were assessable at the end. The first six months included a placebo comparison.
- What did the source report?
- After six months, a blood marker of type I collagen synthesis was higher with GH replacement than with placebo. Researchers also reported significant increases in measured skin thickness at their studied sites during GH substitution. [2]
Keep in context
This was replacement treatment for diagnosed hormone deficiency. It does not demonstrate wrinkle reduction, anti-aging benefit or equivalent effects in healthy people.
What does deep sleep reveal about natural GH secretion?
- Who or what was studied?
- Eight young adults were observed over 38 study nights using overnight blood sampling and sleep-stage measurements.
- What did the source report?
- Seven of eight participants had a major GH secretion peak associated with the onset of deep sleep. Delaying the onset of sleep delayed that peak. [3]
Keep in context
This observed endogenous hormone secretion. It did not administer HGH or test whether taking GH improves sleep quality, duration or recovery.
When is prescription GH replacement supported?
- Who or what was studied?
- Adults evaluated for clinically confirmed growth hormone deficiency, often related to pituitary disease or childhood-onset deficiency.
- What did the source report?
- The Endocrine Society describes benefits of appropriately selected GH replacement in body composition, exercise capacity and some other measures in adults with diagnosed deficiency. The guideline usually calls for confirmation using appropriate testing. [6][4]
Keep in context
Clinical treatment in confirmed deficiency is not evidence that GH is indicated or suitable for otherwise healthy adults, bodybuilding or cosmetic use. Decisions about prescription treatment require individual medical evaluation.
Does HGH work as an anti-aging treatment in healthy adults?
- Who or what was studied?
- A review of 18 unique study populations in community-dwelling older adults without a specific illness being treated; 220 GH recipients completed the included studies.
- What did the source report?
- Across included trials, GH produced relatively small average changes in measured fat and lean mass, while adverse events including edema, joint symptoms and carpal tunnel syndrome were more frequent. [7]
Keep in context
The review found insufficient justification for GH as an anti-aging therapy. Its participants, study designs and treatment durations differ from those in the athlete and deficiency studies.
What risks appear in official somatropin safety information?
- Who or what was studied?
- Patients receiving approved somatropin products in clinical care, and older adults included in GH trials.
- What did the source report?
- The GENOTROPIN label documents fluid retention, joint and nerve-compression symptoms, changes in glucose regulation, intracranial hypertension and other serious warnings or contraindications. Clinicians monitor relevant risks during prescribed treatment. [4][7]
Keep in context
Not everyone experiences these events, and risks depend on the individual and clinical context. This is a selected summary, not the full label, and it does not establish safety or quality for any retail product.
What does FDA-approved somatropin labeling actually establish?
- Who or what was studied?
- Patients meeting the named prescription medicine’s indications and diagnostic criteria.
- What did the source report?
- GENOTROPIN labeling includes defined pediatric indications and adult growth hormone deficiency. It also identifies contraindications, warnings and precautions for clinical prescribing. [4]
Keep in context
Approval and prescribing standards apply to the specific medicine and indicated circumstances. They do not confer approval, equivalence or clinical suitability on a research-product listing.
PUT IT TOGETHER
Common questions
Does increased lean body mass mean increased muscle strength?
No. Lean mass includes water and non-muscle tissue. In the 96-person athlete trial, GH increased measured lean mass partly through extracellular water without a statistically significant improvement in measured strength. [1]
Did HGH improve sprint performance in a human trial?
One randomized athlete trial reported a short-term increase in cycle sprint capacity, but not in measured strength, endurance or jump power. The sprint improvement was not maintained six weeks after treatment stopped. [1]
Does the collagen study prove HGH reduces wrinkles?
No. The controlled trial involved patients with diagnosed GH deficiency and measured collagen markers and skin thickness. It was not a trial of wrinkle reduction or cosmetic treatment in healthy adults. [2]
Does a GH surge during deep sleep mean administering HGH improves sleep?
No. That study measured naturally produced hormone pulses during sleep, not the effects of a GH medicine on sleep. [3]
Is HGH recommended for anti-aging in people without GH deficiency?
A systematic review of trials in healthy older adults found limited body-composition changes, increased adverse effects and insufficient support for GH as anti-aging therapy. [7]
What are important risks mentioned in prescription labels?
Official somatropin labeling describes potential fluid retention, joint symptoms, carpal tunnel symptoms, impaired glucose regulation, intracranial hypertension and other warnings. The complete labeling is needed for the full risk and contraindication profile. [4]
Can human clinical trials verify a research vial sold online?
No. Studies of a named prescription medicine do not verify the identity, contents, purity, approval or suitability of a retail research product. [4]
Key terms, simply explained
- Growth hormone (GH or HGH)
- A hormone naturally secreted by the pituitary gland.
- Somatropin
- Recombinant human growth hormone used in named prescription medicines.
- IGF-1
- Insulin-like growth factor 1, a signaling molecule involved in some GH-mediated effects.
- Endogenous
- Produced naturally inside the body.
- Lean body mass
- Body mass other than fat, including water, muscle, organs and bone.
- Extracellular water
- Fluid outside cells; changes in it can affect lean-mass measurements.
- Placebo-controlled
- A study comparing an intervention with a nonactive comparison group.
- Systematic review
- An evidence synthesis that uses an explicit process to identify and assess relevant studies.
- Biomarker
- A measured biological characteristic that does not necessarily reflect a meaningful health benefit.
- Growth hormone deficiency
- A diagnosed condition in which the body produces insufficient GH; diagnosis requires clinical evaluation and often stimulation testing.
CHECK THE ORIGINALS
Sources and reading notes
Use these links to read the original record. A paper’s title describes the authors’ study; it is not a claim about a product sold by GreysProtocol.
Meinhardt et al. (2010), Annals of Internal Medicine (opens in a new tab)
Growth hormone, body composition and physical performance in recreational athletes
Randomized human trial · Original PubMed abstract rechecked November 4, 2026; full paper not independently assessed.
DOI: 10.7326/0003-4819-152-9-201005040-00007
Kann et al. (1996), Experimental and Clinical Endocrinology & Diabetes (opens in a new tab)
Growth hormone replacement, collagen synthesis and skin thickness in deficient adults
Controlled human study · Original PubMed abstract rechecked November 4, 2026; full paper not independently assessed.
DOI: 10.1055/s-0029-1211462
Takahashi, Kipnis and Daughaday (1968), Journal of Clinical Investigation (opens in a new tab)
Growth hormone secretion during sleep
Human physiology study · Publisher abstract rechecked November 4, 2026; this was a small observational physiology study.
DOI: 10.1172/JCI105893
GENOTROPIN prescribing information, DailyMed (opens in a new tab)
GENOTROPIN indications, contraindications, warnings, precautions and adverse reactions
Official prescribing label · U.S. prescribing label at DailyMed, updated August 4, 2026; indications, warnings and precautions checked November 4, 2026.
OMNITROPE prescribing information, DailyMed (opens in a new tab)
Clinical pharmacology: mechanism of action (section 12.1)
Official prescribing label · Official prescribing information, mechanism of action section 12.1; used only for molecular-pathway context.
Molitch et al. (2011), Endocrine Society clinical practice guideline (opens in a new tab)
Evaluation and Treatment of Adult Growth Hormone Deficiency
Specialist clinical practice guideline · Endocrine Society guideline summary and recommendations rechecked November 4, 2026.
Liu et al. (2007), Annals of Internal Medicine (opens in a new tab)
Systematic review: the safety and efficacy of growth hormone in the healthy elderly
Systematic review of controlled trials · Original PubMed abstract rechecked November 4, 2026; full review not independently assessed.
DOI: 10.7326/0003-4819-146-2-200701160-00005
Continue reading
Explore the foundations and examples of peptide research. Each guide explains its own evidence and limitations.
HGH SINGLE VIALS
View available single-vial options.
